Fox Jonathan C 4
4 · Eidos Therapeutics, Inc. · Filed Sep 18, 2020
Insider Transaction Report
Form 4
Fox Jonathan C
See Remarks
Transactions
- Sale
Common Stock
2020-09-17$50.16/sh−5,767$289,259→ 377,673 total(indirect: See footnote)
Holdings
- 3,294
Common Stock
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.